Identification of mutagenicity, MOA, and dose response analysis

Area of Science:

• Toxicology
• Risk Assessment
• Molecular Biology

Background:

• Traditional cancer risk assessments often rely on rodent tumorigenicity data.
• Evaluating carcinogens requires understanding their mechanism of action (MOA) and dose-response relationships.
• Dietary carcinogens pose a complex challenge for accurate human health risk evaluation.

Purpose of the Study:

• To test a novel cancer risk assessment framework using three known rodent carcinogens: acrylamide, aflatoxin B1, and β-myrcene.
• To evaluate the framework's ability to provide a more nuanced cancer risk assessment compared to traditional methods.
• To assess the human cancer risk associated with dietary exposure to these specific chemicals.

Main Methods:

• The framework integrates gene mutation analysis as an early cancer event indicator.
• It considers dose metrics appropriate to the chemical's MOA.
• Exposure data and dose-response evaluations are used to determine the level of cancer concern.

Main Results:

• Aflatoxin B1's carcinogenicity involves gene mutation as an early event, supporting linear low-dose extrapolation.
• Acrylamide and β-myrcene carcinogenicity data suggest a dose threshold approach.
• Dietary exposure patterns for acrylamide and β-myrcene indicate a low cancer risk.

Conclusions:

• The developed framework offers a more refined approach to cancer risk assessment.
• It provides a better understanding of cancer risk by incorporating MOA and exposure patterns.
• The framework supports more informed risk management decisions for dietary carcinogens.